CDH1 and cancer: Furthermore, aberrant methylation patterns of the CDH1 promoter region were also described in pre-adenoma stages of colorectal cancer, in hyperplasic polyps [65,66] and in ulcerative colitis (a chronic inflammatory condition of the large intestine that predisposes to cancer) [60,67].